# McGuff Pharmaceuticals, Inc., Santa Ana, CA – FDA Inspections

Source: https://www.keypedia.com/companies/mcguff-pharmaceuticals-inc/15443041-ed2c-4d7b-8313-9c85fa0f7bc6

> Inspection records and compliance data for McGuff Pharmaceuticals, Inc. in Santa Ana, California. 13 FDA inspections on record (2 OAI), 4 Form 483s, last inspected April 28, 2025.

---

## Details

- Name: McGuff Pharmaceuticals, Inc.
- FEI Number: 2022073
- Business Operations: FDF MANUFACTURE
- Address Line 1: 2921 W Macarthur Blvd Ste 141
- City: Santa Ana
- State: California
- Zip Code: 92704
- Country Name: United States
- Address: 2921 W Macarthur Blvd Ste 141, Santa Ana, California 92704, United States
- Country: United States

## Related Documents

- [483 - McGuff Pharmaceuticals, Inc. - 2025-04-28](https://www.keypedia.com/records/483/mcguff-pharmaceuticals-inc/3f2a1b4f-952b-4190-8c3c-d5994ef38ea6) — source: FDA, date: April 28, 2025
- [FDA Inspection 1268175 - McGuff Pharmaceuticals, Inc. - 2025-04-28](https://www.keypedia.com/records/fda_inspections/mcguff-pharmaceuticals-inc/cb43831e-bcd5-477c-9ebc-e17f5a1a77de) — classification: Official Action Indicated (OAI), source: FDA, date: April 28, 2025
- [FDA Inspection 1229677 - McGuff Pharmaceuticals, Inc. - 2024-08-20](https://www.keypedia.com/records/fda_inspections/mcguff-pharmaceuticals-inc/65b55a0b-b9f3-46d2-8f5d-7c4d9be18a59) — classification: No Action Indicated (NAI), source: FDA, date: August 20, 2024
- [483 - McGuff Pharmaceuticals, Inc. - 2024-01-26](https://www.keypedia.com/records/483/mcguff-pharmaceuticals-inc/8072bd23-3409-41b9-b04a-7dcc8ccd7185) — source: FDA, date: January 26, 2024
- [FDA Inspection 1228033 - McGuff Pharmaceuticals, Inc. - 2024-01-26](https://www.keypedia.com/records/fda_inspections/mcguff-pharmaceuticals-inc/9da028b1-f0cc-456a-aa9e-f7ff6d6c6300) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 26, 2024
- [FDA Inspection 1110847 - McGuff Pharmaceuticals, Inc. - 2019-11-22](https://www.keypedia.com/records/fda_inspections/mcguff-pharmaceuticals-inc/a143882e-4009-464e-b098-7c78b1df6260) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2019
- [483 - McGuff Pharmaceuticals, Inc. - 2019-03-26](https://www.keypedia.com/records/483/mcguff-pharmaceuticals-inc/9fd8866c-51b6-4238-b894-3feaf84f29af) — source: FDA, date: March 26, 2019
- [FDA Inspection 1083919 - McGuff Pharmaceuticals, Inc. - 2019-03-26](https://www.keypedia.com/records/fda_inspections/mcguff-pharmaceuticals-inc/05ba6d7a-07df-457c-960a-a85328df7c45) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 26, 2019
- FDA Inspection 1013240 - McGuff Pharmaceuticals, Inc. - 2017-06-02 — classification: No Action Indicated (NAI), source: FDA, date: June 2, 2017
- [FDA Inspection 1010923 - McGuff Pharmaceuticals, Inc. - 2017-03-31](https://www.keypedia.com/records/fda_inspections/mcguff-pharmaceuticals-inc/5fff839d-7396-49b4-a06d-b1c8c086c1f0) — source: FDA, date: March 31, 2017
- [FDA Inspection 908368 - McGuff Pharmaceuticals, Inc. - 2014-12-31](https://www.keypedia.com/records/fda_inspections/mcguff-pharmaceuticals-inc/70c27e45-066c-445c-8719-327529991c4d) — classification: Official Action Indicated (OAI), source: FDA, date: December 31, 2014
- FDA Inspection 872488 - McGuff Pharmaceuticals, Inc. - 2014-03-27 — classification: No Action Indicated (NAI), source: FDA, date: March 27, 2014
- FDA Inspection 834425 - McGuff Pharmaceuticals, Inc. - 2013-05-31 — classification: No Action Indicated (NAI), source: FDA, date: May 31, 2013

## Related Companies

- [Silliker Laboratories Group, Inc](https://www.keypedia.com/companies/silliker-laboratories-group-inc/a9d53aca-972c-488b-a699-d41cdadcf067)
- [Douglas Glenn Young, M.D.](https://www.keypedia.com/companies/douglas-glenn-young-md/8df28cec-c379-4bbf-a055-6f2996fa1da3)
- [Tran-Johnson, Tram K.](https://www.keypedia.com/companies/tran-johnson-tram-k/16da73c1-72e8-4420-a409-9c9e7130b7f5)
- [H J Harkins Company Inc dba Pharma Pac](https://www.keypedia.com/companies/h-j-harkins-company-inc-dba-pharma-pac/f91872b7-2f46-4d40-ae2c-32afca97df2e)
- [Ranbaxy Inc.](https://www.keypedia.com/companies/ranbaxy-inc/83cb62ce-f991-473a-a24b-f5951066c481)
- [Matrixx Initiatives, Inc.](https://www.keypedia.com/companies/matrixx-initiatives-inc/7fbc68ac-c0d4-4034-af19-6bd954d17e4d)
- [Amryt Pharmaceuticals, Inc.](https://www.keypedia.com/companies/amryt-pharmaceuticals-inc/bfdef8ed-47d6-408f-a59b-16c2f17d796a)
- [Patheon Biologics (NJ) LLC](https://www.keypedia.com/companies/patheon-biologics-nj-llc/5d009aee-a952-4eee-a975-1b2bd0559e04)
- [Daniel J. DeAngelo, MD](https://www.keypedia.com/companies/daniel-j-deangelo-md/9a6d0cc8-13b8-4412-b0b4-933a9ef1352c)
- [U.S. Army Medical Research Institute of Infectious Diseases](https://www.keypedia.com/companies/us-army-medical-research-institute-of-infectious-diseases/6d9547df-bbd2-48e8-ba75-d633d911af27)

## Related Officers

- [Laboratory Director](https://www.keypedia.com/people/jennifer-m-gogley/2025f306-80a6-4222-89ac-e4138028292a)
- [Pharmaceutical investigator](https://www.keypedia.com/people/bryan-a-galvez/d1e52abc-5b56-4ffb-af22-90e6733fb73a)
- [Pearl C. Ozuruigbo](https://www.keypedia.com/people/pearl-c-ozuruigbo/28ec383e-a602-4764-8d14-20b1049f93d7)
- [Microbiologist](https://www.keypedia.com/people/michael-t-cyrus/30e497e1-2c17-4dd7-9a5b-251771cf4266)
- [Chemist/Investigator - Pharmaceutical Quality](https://www.keypedia.com/people/walden-h-lee/18131eea-d1cb-47c4-af79-bea22d436031)
- [Cecilia H. Kieu](https://www.keypedia.com/people/cecilia-h-kieu/3ba5feb0-d49e-4301-ae5c-b84bd604a159)
